This site uses cookies to store information on your computer. Learn more x

Consensus Figures

A number of international financial analysts cover DSM. The most recent consensus figures – provided by Vara Research – are detailed below. The figures are based on the estimates given by the banks that were approached by Vara Research.

Analysts' consensus Q2 2017 and FY 2017 published 19 July 2017

  Q2 2016 FY 2016 Q2 2017 E FY 2017 E
Sales (continuing)        
  Number of Estimates     23 23
  Highest     2,200 8,529
  Consensus 1,994 7,920 2,137 8,426
  Median     2,139 8,452
  Lowest     2,060 8,158
EBITDA (continuing)        
  Number of Estimates     23 23
  Highest     365 1,416
  Consensus 328 1,262 355 1,375
  Median     354 1,373
  Lowest     341 1,293
EBIT (continuing)        
  Number of Estimates     21 23
  Highest     245 938
  Consensus 211 791 233 886
  Median     234 888
  Lowest     218 811
Nutrition, Sales        
  Number of Estimates     23 23
  Highest     1,420 5,531
  Consensus 1,295 5,169 1,369 5,442
  Median     1,369 5,462
  Lowest     1,310 5,249
Nutrition, EBITDA        
  Number of Estimates     23 23
  Highest     272 1,059
  Consensus 237 931 258 1,013
  Median     258 1,014
  Lowest     251 961
Nutrition, EBIT        
  Number of Estimates     20 21
  Highest     200 768
  Consensus 165 645 186 720
  Median     185 722
  Lowest     176 670
Materials, Sales        
  Number of Estimates     23 23
  Highest     740 2,828
  Consensus 640 2,513 707 2,738
  Median     708 2,737
  Lowest     672 2,579
Materials, EBITDA        
  Number of Estimates     23 23
  Highest     130 484
  Consensus 117 435 121 458
  Median     121 456
  Lowest     115 433
Materials, EBIT        
  Number of Estimates     20 21
  Highest     94 356
  Consensus 86 311 89 331
  Median     89 329
  Lowest     81 303
Innovation Center, Sales        
  Number of Estimates     23 23
  Highest     46 184
  Consensus 40 167 43 174
  Median     43 175
  Lowest     40 166
Innovation Center, EBITDA        
  Number of Estimates     23 23
  Highest     3 12
  Consensus 0 1 1 5
  Median     1 5
  Lowest     -2 -4
Innovation Center, EBIT        
  Number of Estimates     20 21
 Highest     -3 -14
  Consensus -5 -24 -5 -20
  Median     -5 -20
  Lowest     -8 -29
Corporate Activities, Sales        
  Number of Estimates     23 23
  Highest     20 77
  Consensus 19 71 18 71
  Median     19 71
  Lowest     16 68
Corporate Activities, EBITDA        
  Number of Estimates     23 23
  Highest     -23 -90
  Consensus -26 -105 -26 -102
  Median     -26 -101
  Lowest     -30 -110
Corporate Activities, EBIT        
  Number of Estimates     20 21
  Highest     -31 -133
  Consensus -35 -141 -36 -142
  Median     -35 -141
  Lowest     -43 -162
Profit for the period, before exceptional items - Cont. Ops.        
  Number of Estimates     20 20
  Highest     189.8 712.6
  Consensus 135.0 508.0 171.2 646.8
  Median     171.1 648.2
  Lowest     144.6 532.4
Net EPS before exceptional items - Cont. Ops.        
  Number of Estimates     20 20
  Highest     1.08 4.07
  Consensus 0.76 2.89 0.97 3.66
  Median     0.96 3.67
  Lowest     0.83 3.04

DSM Disclaimer

Consensus earnings estimates are based on earnings projections made by securities analysts who cover DSM. Any opinions, forecasts, estimates, projections or predictions regarding DSM’s performance made by the analysts (and, therefore, the Consensus estimate numbers) are theirs alone and do not represent the opinions, forecasts, estimates, projections or predictions of DSM or its management. DSM does not by providing these estimates imply its endorsement of or concurrence with such information, conclusions or recommendations. DSM assumes no liability for the accuracy of such estimates and undertakes no obligation to update or revise such estimates.